Daliresp is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Roflumilast.
| Product ID | 0310-0088_5daa2c1b-1fe2-4c32-b17c-fba76ce5965e | 
| NDC | 0310-0088 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Daliresp | 
| Generic Name | Roflumilast | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2015-07-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022522 | 
| Labeler Name | AstraZeneca Pharmaceuticals LP | 
| Substance Name | ROFLUMILAST | 
| Active Ingredient Strength | 250 ug/1 | 
| Pharm Classes | Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2018-01-23 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022522 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2018-01-23 | 
| Marketing Category | NDA | 
| Application Number | NDA022522 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2018-01-23 | 
| Marketing Category | NDA | 
| Application Number | NDA022522 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2018-01-23 | 
| Ingredient | Strength | 
|---|---|
| ROFLUMILAST | 250 ug/1 | 
| SPL SET ID: | c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0310-0088 | Daliresp | roflumilast | 
| 0310-0095 | Daliresp | roflumilast | 
| 55154-4625 | Daliresp | roflumilast | 
| 0378-1905 | Roflumilast | Roflumilast | 
| 13668-476 | Roflumilast | Roflumilast | 
| 31722-623 | Roflumilast | Roflumilast | 
| 42571-259 | ROFLUMILAST | Roflumilast | 
| 43547-005 | ROFLUMILAST | roflumilast | 
| 64380-786 | roflumilast | ROFLUMILAST | 
| 68382-969 | Roflumilast | Roflumilast | 
| 70771-1674 | Roflumilast | Roflumilast | 
| 72205-200 | Roflumilast | Roflumilast | 
| 72205-201 | Roflumilast | Roflumilast | 
| 80610-130 | roflumilast | roflumilast | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  DALIRESP  85265098  4055617 Live/Registered | Nycomed GmbH 2011-03-11 | 
|  DALIRESP  77947508  4003351 Live/Registered | Nycomed GmbH 2010-03-01 | 
|  DALIRESP  75876181  not registered Dead/Abandoned | ALTANA PHARMA AG 1999-12-21 |